01 1Maprimed
01 1NITAZOXANIDE
01 1Argentina
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-01-24
Pay. Date : 2019-12-03
DMF Number : 34150
Submission : 2019-12-18
Status : Active
Type : II
20
Maprimed Sa, based in Argentina, is a pharmaceutical company.
One of their notable products is NITAZOXANIDE, with a corresponding US DMF Number 34150.
Remarkably, this DMF maintains an Active status since its submission on December 18, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 24, 2020, and payment made on December 03, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
